Get alerts for new trials in your area by subscribing now
Insomnia clinical trials are structured research studies built to test whether a particular approach, a medication, a behavioral program, or a monitoring device, actually helps people sleep better. Rather than relying on personal experience alone, researchers gather data across many participants to see what patterns hold up and what genuinely makes a difference.
This kind of research also looks beyond just falling asleep faster. Many studies track daytime energy, mood, and overall quality of life, since poor sleep tends to affect a lot more than just the nighttime hours.
Sleep is something almost everyone struggles with at some point, which makes insomnia one of the most widely studied sleep conditions. Research suggests that 30–35% of adults experience brief insomnia symptoms, 15–20% develop short-term insomnia lasting under three months, and 10% live with chronic insomnia, occurring three or more times a week for three months or longer, showing that insomnia isn't one single experience, but a spectrum.
Clinical trials matter here because they give researchers a structured way to compare different approaches side by side, rather than relying on anecdotal reports of what seems to help. Beyond individual results, this kind of research also feeds into broader clinical guidance, shaping how sleep difficulties are understood and addressed in everyday practice over time.
Yes, insomnia's effects reach well beyond just feeling tired. Ongoing sleep loss has been linked to a higher risk of depression and high blood pressure, and it can affect memory, concentration, and mood over time. There's a real economic side to it too: insomnia is linked to an estimated $63 billion in lost work performance across the US workforce every year, with individual employees losing around eight days of productivity annually because of it. These wider effects are part of why clinical trials continue to study insomnia, as something that touches overall health and daily functioning.
Not everyone who has trouble sleeping will qualify for every insomnia trial, each study sets its own criteria based on what's being tested. Broadly speaking, most trials look for adults who've had ongoing sleep difficulties for a certain length of time, whether insomnia is the main concern or something that developed alongside another condition.
Researchers typically screen for things like age, general health, current sleep habits, and any medications or sleep aids already in use. Some studies also enroll people with healthy, regular sleep as a comparison group.
Before anything else happens, participants go through a screening stage, often involving sleep questionnaires or a short sleep diary, to see whether they're a good fit for the study. Once that's confirmed, the research team explains everything through informed consent: what the study involves, what's being tested, and what risks or benefits participants should know about going in.
From there, participation can look different depending on the trial, some people follow a structured behavioral sleep program, others receive a medication or placebo, and some wear a device that tracks sleep overnight. Regardless of the format, regular check-ins are typically built in to see how things are progressing.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Insomnia studies span a few distinct types of trials, each looking at a different way to help people fall asleep more easily, stay asleep through the night, and feel more rested during the day. Because insomnia can be approached in several different ways, from behavioral changes to medication to digital tools, researchers often study more than one method at a time to see what actually works best for different people.
Medication trials test sleep medications, including a drug class called orexin receptor antagonists, which has been a major focus of recent insomnia research. Participants are typically adults with a diagnosed sleep difficulty, and studies often track how well a medication helps someone fall asleep, stay asleep, or feel rested the next day.
These trials test structured behavioral sleep programs, often delivered through an app or smartphone, sometimes referred to as digital CBT-I. Participants usually include people looking to improve their sleep without medication, or those using it alongside a medication-based approach, with progress tracked through sleep diaries or app-based data.
These trials use wearable devices, like smart rings, to track sleep patterns and see how well a behavioral or medication-based approach is working over time. Participants wear the device throughout the study, and researchers use the data collected to measure changes in sleep quality more precisely than self-reporting alone.
Enrolling in an Insomnia clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: